Research Frontiers REFR
- Market cap
- $16.1M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 24.6×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $654.2K
- −46% on a year ago
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- −9.7%
Research Frontiers trades at 24.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $654.2K over the last twelve months, down 46% on a year earlier.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $164.1K+9% | $312.2K+140% | $313.4K+26% | $489.6K+165% | $354.4K+116% | $178.2K−43% | $559.8K+79% | $129.9K−74% | $359.4K+1% | $72.1K−60% | $136.3K−76% | $86.3K−34% | |
| R&D | $135.3K−9% | $153.1K−7% | $149.7K+0% | $128.8K−12% | $131.2K−3% | $160.2K+5% | $162.9K+9% | $169.1K+31% | $141.7K+8% | $135K−16% | $145.3K−11% | $128.9K−24% |
| SG&A | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| −$513.8K+6% | −$505.4K−38% | −$469.8K−4% | −$116.1K−78% | −$231.7K−55% | −$624.3K+24% | −$239.6K−49% | −$815.1K+602% | −$303.9K+31% | −$773.5K+24% | −$530.4K+121% | −$669.8K−18% | |
| Pre-tax income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Net income | −$472.2K−2% | −$479.9K−41% | −$442.6K−4% | −$94K−81% | −$166.8K−65% | −$607.9K+27% | −$177.7K−60% | −$803.8K+755% | −$298.5K+79% | −$765.6K+26% | −$525.4K+196% | −$660.2K−18% |
| −$0.01−50% | −$0.01−50% | −$0.01+0% | $0.00 | $0.00 | −$0.02+100% | −$0.01+0% | −$0.02 | −$0.01 | −$0.02+0% | −$0.02+100% | −$0.02+0% | |
| 33.5M+5% | 33.5M+1% | 33.5M+1% | 33.5M+0% | 33.5M+0% | 33.5M+0% | 33.6M+0% | 33.6M+0% | 33.6M+0% | 33.6M+0% | 34.2M+2% | 34.9M+4% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 14 periods, Q4 FY12 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Asset Management nearest Research Frontiers' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| REFRResearch Frontiers | $16.1M | n/m | n/a | 24.6× | −46% | n/m | |
| GROWU S Global Investors | $32.3M | 10.9× | 18.7× | 3.1× | +21% | 29.8% | |
| HNNAHennessy Advisors | $80.5M | 9.7× | 9.2× | 2.4× | −7% | 24.8% | |
| JYNTJOINT | $101.9M | 26.7× | 68.0× | 1.7× | +9% | 6.5% | |
| SAMGSilvercrest Asset Management | $119.9M | 92.0× | 15.7× | 1.0× | +1% | 0.7% | |
| Peer median | $91.2M | 18.8× | 17.2× | 2.1× | +5% | 15.6% |
More on Research Frontiers
Each number over time
Its groups
About
- Industry
- Asset Management
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .